In today’s Market 360, let’s dive into Microsoft’s partnership with OpenAI and then review the company’s second-quarter earnings.
These micro-cap stocks have tremendous growth potential and a history of big moves, but they also come with plenty of volatility.
With key issues not quite yet in the rearview mirror, steering clear of NIO stock continues to be best move to make.
LLY stock investors were winners in 2022, and Eli Lilly's expanding pipeline points to possible further gains for patient shareholders.
I’ve discussed the market’s gyrations and many of the big distractions in my Growth Investor Special Market Podcasts. But given the recent wild swings, I’d like to briefly review a few of the biggest recent headlines in today’s Market 360,…